Podcasts about qol

Welcome to RetroLogic! I'm Dan Caporello here with Shannon Eno and John Cummins, and Adam Caporello! Intros   But RetroLogic isn't just a podcast. It's a community of retro gamers! - We've got an active, friendly, and free discord. - Giveaways - Contests - AND Dive into our family of Retro podcasts! Like RetroGroove, a music history podcast, and On Topic Retro, a podcast dedicated to 1 video game per episode hosted by our very own John Cummins. - you can find everything at our website retrologic.games   Housekeeping John - New retrologic content coming!   On Topic Retro - Gradius Interstellar Assault for Game Boy The Price Is Retro If this is your first time playing Price Is Retro, here's how we play. I'm going to list off 4 or 5 games and everyone has to guess how much the lot is worth in total. Whoever is closest to the actual value wins that round! Everyone has a list and everyone guesses on each other's list.    At the end, the player that won the most rounds wins the episode! But watch out for the robot Deus Guess Machina! He averages all of our guesses together for his own guess Dinosaur - Leonard - adds up original costs, retail value Ghost - Polterguest - always guesses 300 Shannon's List Dan's List Adam's list John's List Show Topic - remake/remaster/reimagining  Which do you prefer?   What is your favorite game that has had one of these treatments? Third Strongest Mole — 6/13/26, 8:47 AM I'll try to give my condensed thoughts here since I wont' make it onto next week's show. The only remakes that I consider justified are games that truly had potential they failed to live up to. Games that are perfectly good as they are don't need remakes - just ports. While I appreciate keeping classic games available for people who don't have original hardware, ports address that problem in a much more cost effective way - and the "need" for remasters is selling a solution to a problem created by the planned obsolescence of the idea of console generations. We don't actually need new hardware (at least not to play old games)- console makers just need new hardware and software to sell. By all means keep the classics available through reprints and officially licensed emulation. But those aren't new releases and we shouldn't pretend they are. If you really "can't wait to play Ocarina of time again" - plug in the N64, or boot up the NSO app. Community Couch Savannah the Hyena Queen — 6/12/26, 6:59 PM I like remakes, for two reasons. One, they allow a new generation of players to experience an old game with the conveniences of the modern era. And two, they give fans a brand new way to experience their favorite games. Pokémon Omega Ruby and Alpha Sapphire was the first point for me, and Brilliant Diamond and Shining Pearl was the second. That being said, I think Nintendo has been doing too many remakes and updates to old games recently and not enough new ones. But maybe that's just cause I'm not super interested in Star Fox or Ocarina of Time Drex1981 [ARC],  — 6/12/26, 7:04 PM Remakes are tricky things. One of the side they can fix issues that at the time couldn't be addressed. They can expand on storylines and tell the story with more detail. They can introduce new players to these games and create new fans. On the other side they can be souless cash grabs and change what makes these games great. MooseGooseNinja [SEAF],  — 6/12/26, 7:18 PM I like remakes as long as they do the original game justice (looking at RE3R), but otherwise I do like the idea of remakes for the same reasons Savannah mentions. I generally try to judge remakes on a case-by-case basis though, and my personal favorite part of remakes is playing both versions (if I can get my hands on the original) and comparing and contrasting the two. I also try not to decide which is better or anything, but just objectively finding differences. It was the most fun for RE4 because I LOVE those games. My favorite game that got a remake was probably Dead Space. DoubleD — 6/12/26, 8:57 PM I've been mulling this over for a bit now and I think I like remasters the most. Making older games accessible to a new audience while improving the graphics and QoL features will get me every time (Don't ask me how many versions of the various Final Fantasy games I've bought through the years). Final Fantasy Tactics: The Ivalice Chronicles is probably my favorite remaster though. It kept one of my favorite games mostly the same but added amazing voice acting that let me experience one of my favorite video game stories in a completely different way! Your Wallet's Defense Attorney — 6/13/26, 12:16 AM I prefer remakes that change stuff more than faithful remakes. They are more interesting to analyze, and they provide more of a reason to play them if you have access to the original. Solo [nDAD],  — 6/13/26, 8:37 AM I welcome a remaster of the game. The trend now in console camps is to remaster games to bring them into the contemporary level of graphics and/or new art design to make them more appealing to new generation of gamers. OoT is a cherished entry into the Zelda series. Off of this one entry we get the branches into the Downfall causing BoTW/ToTK, Child and Adult timelines of Zelda lore. Would be interesting if in the remaster then made methods to connect the game to others; for example the lore we see in BoTW/ToTK that many have played (even those that are not deep dive Zelda fanboys and just played off IP recognition alone). Hoping myself the remaster is not a lockstep redo of the original since that version is already out there. I find it more exciting if they were to add new story beat elements into a new artwork scheme. adam — 6/13/26, 9:25 AM i find the discourse around remakes and remasters to be kind of pointless, because if you don't like them, just don't play them.   is there a conversation to be had about companies rereleasing games instead of taking risks on new ips? yeah absolutely. but i think that's different then should these remakes/remasters exist.   emulation and ports are important in the preservation of media, but remakes/remasters   update games to be more accessible on modern hardware.   remakes/remasters recontextualize their stories into the modern broader canon.   i think people are excited to play oot remake/remaster because of the first two reasons. i don't think anyone would pretend that the z targeting and camera controls in the original are good. (innovative for the time but obviously not great in comparison to today) so updated qol features, coupled with excitement to see how they will recontextualize oot to better fit with the current branch of botw/totk, and hopefully give us a glimpse of what's to come next   (In response to adam) Your Wallet's Defense Attorney — 7:56 AM People get annoyed about remakes because of the opportunity cost. Time you take developing a remake/remaster is time you could have spent developing something new. So there are some stakes to the discussion. Also, as a community based around gaming, we like talking about games. So we wanna talk about whether remakes/remasters are interesting to us, and listen to how other like minded people feel about them. The discussion itself is often the point. (Adam thinks the opportunity cost argument doesn't hold water because plenty of studios are able to output both) (Flightsy says there is STILL an opportunity cost. And resources were spent) (Adam responds) adam — 12:16 PM I can't recall a situation where a new game or a game that's in development was sidelined by a remake/remaster. if anything the remakes and remasters make studios more money to put into new titles.   …   but like i said i think really the bigger issue in the industry is the live service model/microtransactions being pushed by suits in c-suites. it's why naughty dog hasn't dropped anything, it's why xbox is in such a bad spot financially. *and then to fill the void of canceled games companies just rerelease or remaster something   …   i think it's an interesting topic, and i think that the recent uptick in remakes/remasters is a barometer for the health of the current industry. and if it's good or bad is up to interpretation, or more likely somewhere in the middle Xomber — 1:35 PM Have mixed feelings on remakes. Some games are just classics and it doesn't really do much to put a fresh coat of paint on a classic. I will still play them, however, hence the mixed feelings. Like when Last of Us 2 was remade on the PS5, it seemed, pointless to me, but since I hadn't played it up until that point that'd be the option I would go with. I still like good games being remade to a certain extent, but are we going to do that every 5-10 years or every 2-3 generations? Xomber — 1:39 PM Another thing I wonder, would a remake make some bad games good? I'm curious about that. Could a story be fleshed out more, or an annoying game mechanic be improved to where it's not cumbersome? That's what actually interests me. Flightsy: I was definitely disappointed by the OOT remake announcement, and in general by the large amount of old content on the Switch 2. But in the end, that's not actually what I'm disappointed about. I'm disappointed that a year in, I still don't really feel compelled to buy the Switch 2. I'm annoyed about the remasters because it reminds me of that core issue, but it isn't actually the issue itself. And there's no way to know if a decision not to make those remasters would have actually led to a world that fixes that issue… Thanks for listening to the RetroLogic Podcast! We are proudly part of the Nintendo Dads family of podcasts. If you like what you hear, check me out on Bluesky at @retrologicgames.bsky.social. You're also welcome to jump into our friendly and 100% non-toxic Discord Community! The link to that is in my Blusky bio. You can also find everything on our website Retrologic.games

Is Mixtape a “real game”? Honestly, who cares; we love this coming-of-age story set in the 90s from Beethoven and Dinosaur, through Annapurna Interactive. It's quick, it's robust, and it's memorable, and that's what we're after from narrative-focused experiences like this. Snackaroo is advanced Snap by way of Aardman, for up to 5 players, and while it's a children's game for sure, it's got enough meat in the bun for the parents of those kids too. It's from Rudi Biber and Ravensburger, and we really like it. Plus the wood glue is out for a QoL project to make a complex setup more simple, with the Descent 2nd Edition organiser from The Game Doctors, via Feldherr. All that, and being famous for five minutes on r/CasualUK, on Ep249. 00:00 - Getting Creami with ninjas 09:47 - Snackaroo 22:00 - Kris's house is famous 25:15 - Mixtape 49:44 - Getting sticky with The Game Doctors on Feldherr On this episode were Kris (@DigitalStrider), Peter (@XeroXeroXero), and Sam (@MrSamTurner). Our Spotify Playlist brings together lots of great thematic music inspired by the stuff we talk about, our Steam Curator page collects every video game we've ever reviewed available on the platform, and our BoardGameGeek page does the same for every boardgame. And if you'd like to see what we're up to between podcasts, your best bet is our Instagram page. Links to where you can find us - StayingInPodcast.com Note: sometimes we'll have been sent a review copy of the thing we're talking about on the podcast. It doesn't skew how we think about that thing, and we don't receive compensation for anything we discuss, but we thought you might like to know this is the case.

松村邦洋さんの名言 / 挨拶の重要性 / 気遣いのコミュニケーション / 年齢と気遣いの変化 / 贈り物の意義 / 挨拶とQOLの関係 / 贈り物の選び方 / 気遣いの心理 / 挨拶のマナー / 贈り物とコミュニケーション / 家庭のしつけとマナー / 挨拶しない自由？ / 人との触れ合いの重要性■ 番組への感想・お便りはこちらhttps://bit.ly/3TK21mu⁠■ クレジットOpening Theme : Composed by WATACover Artwork : Designed by WATACG Character : Modeling & Designed by WATAEnding Theme : Composed by TAZAWA©終わりかけのRadio番組エンディングテーマ『life』https://bit.ly/4aHZ1wU#松村邦洋 #挨拶 #マナー

Summer scheduling chaos is in full swing as Dylan and Max talk vacation bidding wizardry, Teterboro's RNAV to Runway 1, NDB war stories, New York hotel-room misery, and a suspiciously affectionate airline lobby ritual. In the Mailbag, they tackle foreign pilots at U.S. carriers, terrifying hotel van rides, AI app-building tools, and a listener plea to stop stepping on each other's punchlines. For Flight Advice, they answer a 300-hour CFI wondering how to build an interesting aviation career while still protecting family life, QOL, and future seniority. TankerBot AI in Business Aviation LinkedIn Group Show Notes 0:00 Intro & Pagers 4:59 Vacation Slide 8:53 New RNAV Approach 15:02 Max's Musings & Kissing Conundrum 23:25 Carbon Cub Jacket 26:35 News: 737 Production 31:40 Reviews & Comments 33:57 Mailbag 44:06 Flight Advice Our Sponsors Tim Pope, CFP® — Tim is both a CERTIFIED FINANCIAL PLANNER™ and a pilot. His practice specializes in aviation professionals and aviation 401k plans, helping clients pursue their financial goals by defining them, optimizing resources, and monitoring progress. Click here to learn more. Also check out The Pilot's Portfolio Podcast. Advanced Aircrew Academy — Enables flight operations to fulfill their training needs in the most efficient and affordable way—anywhere, at any time. They provide high-quality training for professional pilots, flight attendants, flight coordinators, maintenance, and line service teams, all delivered via a world-class online system. Click here to learn more. Raven Careers — Helping your career take flight. Raven Careers supports professional pilots with resume prep, interview strategy, and long-term career planning. Whether you're a CFI eyeing your first regional, a captain debating your upgrade path, or a legacy hopeful refining your application, their one-on-one coaching and insider knowledge give you a real advantage. Click here to learn more. The AirComp Calculator™ is business aviation's only online compensation analysis system. It can provide precise compensation ranges for 14 business aviation positions in six aircraft classes at over 50 locations throughout the United States in seconds. Click here to learn more. Vaerus Jet Sales — Vaerus means right, true, and real. Buy or sell an aircraft the right way, with a true partner to make your dream of flight real. Connect with Brooks at Vaerus Jet Sales or learn more about their DC-3 Referral Program. Harvey Watt — Offers the only true Loss of Medical License Insurance available to individuals and small groups. Because Harvey Watt manages most airlines' plans, they can assist you in identifying the right coverage to supplement your airline's plan. Many buy coverage to supplement the loss of retirement benefits while grounded. Click here to learn more. VSL ACE Guide — Your all-in-one pilot training resource. Includes the most up-to-date Airman Certification Standards (ACS) and Practical Test Standards (PTS) for Private, Instrument, Commercial, ATP, CFI, and CFII. 21.Five listeners get a discount on the guide—click here to learn more. ProPilotWorld.com — The premier information and networking resource for professional pilots. Click here to learn more.   Feedback & Contact Have feedback, suggestions, or a great aviation story to share? Email us at info@21fivepodcast.com. Check out our Instagram feed @21FivePodcast for more great content (and our collection of aviation license plates). The statements made in this show are our own opinions and do not reflect, nor were they under any direction of any of our employers.

NHK「みんなで筋肉体操」でおなじみの谷本道哉先生が、筋トレ「ランジ」をイチオシしています。人生100年時代と言われますが、実は筋肉は、40代ごろから加齢とともに落ちていきます。つまづきや転倒によって、QOL（生活の質）が低下することも。「つまずくことが増えた」「バランスをとりにくくて、階段を下りるのが怖い」「昔より速く歩けない」などの背景には、実は筋肉の衰えがあります。とくに落ちやすい筋肉が、下半身です。腸腰筋・大殿筋・大腿四頭筋などが健康的な生活を送る上で重要ですが、足腰を鍛える筋トレの代表「スクワット」でさえ、すべてを一度に鍛えることができません。そこで、おすすめしたいのが「ランジ」です。谷本道哉（たにもと・みちや）順天堂大学大学院スポーツ健康科学研究科 先任准教授2006年東京大学大学院総合文化研究科博士課程修了。博士（学術）。国立健康・栄養研究所特別研究員、順天堂大学博士研究員、近畿大学生物理工学部准教授などを経て、現職。専門は身体運動科学、筋生理学。メディア出演も多く、NHK「みんなで筋肉体操」「おはよう日本 おはSPO×筋肉体操」やテレビ朝日「モーニングショー」など数多くの番組で、筋肉の働きや体を鍛えることの重要性を伝えている。商品名：別冊NHKきょうの健康　はじめよう ランジ筋トレ　スクワット超えの「健脚効果」で、もうつまずかない、転ばない！著者：谷本道哉出版社：NHK出版発売日：2022年10月19日定価：990円（税込）判型：B5判並製ページ数：96ページ（内カラー48ページ）⇒「ランジ筋トレ」とはランジ筋トレは、体を支え、速く歩くために重要な筋肉のほぼすべてを鍛えることができる、画期的な筋トレです。次：やり方も簡単！やり方も簡単。まずは、片方の足を大きく前に一歩踏み出して、腰を落とします。体勢としては不安定になりますが、机に手を添えることで転ばずに行えます。踏み込む距離などを調節することで、誰でも行うことができます。手軽なのに効果がスクワットを超えるとなると、続けるしかないですね。ちなみに、机を使わない通常のランジは以下の通り。

Health-Related Quality of Life after Guided Growth Treatment for Hip Displacement in Young Children with Cerebral Palsy

In this episode of HPNA Palliative Perspective, we're joined by Betty Ferrell—Editor of the Journal of Hospice & Palliative Nursing (JHPN), nurse, and internationally recognized researcher. As the leader of the End-of-Life Nursing Education Consortium, she brings a unique perspective shaped by decades of connection with hospice and palliative care nurses across the U.S. and around the world.  Now in her 49th year in nursing—beginning in oncology and entering hospice as it emerged in the United States—Dr. Ferrell reflects on the remarkable growth of the field and where we stand today.  At the heart of this conversation is the idea of a “professional home.” Drawing on the foundational work of pioneers like Florence Wald and Cicely Saunders, she highlights the enduring importance of interprofessional, whole-person care—and the need to stay grounded in those values as the field evolves.  In a time that can feel complex and demanding, this episode offers a clear message: you don't have to do this work alone. Finding your people, building community, and staying connected—through colleagues and organizations like the Hospice and Palliative Nurses Association—are essential to sustaining both practice and purpose.  A thoughtful and reassuring conversation about belonging, connection, and the future of hospice and palliative nursing.      Betty Ferrell, RN, PhD, MA, CHPN®, FAAN, FPCN® Betty Ferrell, RN, PhD, MA, CHPN®, FAAN, FPCN® has been in nursing for 48 years and has focused her clinical expertise and research in pain management, quality of life, and palliative care. Dr. Ferrell is the Director of Nursing Research & Education and a Professor at the City of Hope Medical Center in Duarte, California. She is a Fellow of the American Academy of Nursing and she has over 500 publications in peer-reviewed journals and texts. She is Principal Investigator of the “End-of-Life Nursing Education Consortium (ELNEC)” project. She directs several other funded projects related to palliative care in cancer centers and QOL issues. Dr. Ferrell was Co-Chairperson of the National Consensus Project for Quality Palliative Care. Dr. Ferrell completed a Masters degree in Theology, Ethics and Culture from Claremont Graduate University in 2007. She has authored 12 books including the Oxford Textbook of Palliative Nursing (5th Edition, 2019) published by Oxford University Press. She is co-author of the text, The Nature of Suffering and the Goals of Nursing published by Oxford University Press (2nd Ed, 2023) and Making Health Care Whole: Integrating Spirituality into Patient Care (Templeton Press, 2010). In 2013 Dr. Ferrell was named one of the 30 Visionaries in the field by the American Academy of Hospice and Palliative Medicine. In 2019 she was elected a member of the National Academy of Medicine. In 2021 Dr. Ferrell received the Oncology Nursing Society Lifetime Achievement Award and she was inducted as a “Living Legend” by the American Academy of Nursing   Brett Snodgrass, DNP, FNP-C, ACHPN®, FAANP Dr. Brett Snodgrass has been a registered nurse for 28 years and a Family Nurse Practitioner for 18 years, practicing in multiple settings, including family practice, urgent care, emergency departments, administration, chronic pain and palliative medicine. She is currently the Operations Director for Palliative Medicine at Baptist Health Systems in Memphis, TN. She is board certified with the American Academy of Nurse Practitioners. She is also a Fellow of the American Association of Nurse Practitioners and an Advanced Certified Hospice and Palliative Nurse. She completed a Doctorate of Nursing Practice at the University of Alabama – Huntsville. She is a nationally recognized nurse practitioner speaker and teacher. Brett is a chronic pain expert, working for more than 20 years with chronic pain and palliative patients in a variety of settings. She is honored to be the HPNA 2025 podcast host. She is married with two daughters, two son in laws, one grandson, and now an empty nest cat. She and her family are actively involved in their church and she is an avid reader.

〜Today's Chapter〜 0:52 QOL底辺達のオフの過ごし方、聞きたい？ 6:20 いくつになってもイイ男には目がないの♡ ☆☆☆☆☆☆☆☆☆☆☆☆☆☆☆☆☆☆☆☆☆☆☆ おたよりフォーム「荒山セントラル郵便局」。 Radiotalk以外のプラットフォームからのドスラヂへの質問、感想等はこちらからどうぞ♡ https://forms.gle/Xw34h8hQBimuuQFv6 ソロラヂも極稀に配信中♡ ☆ぺそどコ→ https://radiotalk.jp/program/22542 ☆やしこのぼちラヂ→ https://radiotalk.jp/program/44603 ※「やしこのぼちラヂ」はラジオトークからのみ聴取可能です 各ソロラヂヲ専用のおたよりフォームが出来ました。 ☆ぼちラヂ専用「若杉浜際郵便局」→ https://forms.gle/fLZHQurNX234Wm1d7 ☆ぺそどコ専用「空豆川淵郵便局」→ https://forms.gle/MTao8NPqebxiQgK46 ダイレクトなおたよりは是非こちらへ！お待ちしてます♡ ☆26/5/23収録 BGM：「Bloom Bloom」by shimtone #2人組 #LGBTQ+ #GayTalker #収録配信型トーカー #パーキング収録 #ぶりっ子倶楽部 #ぶりっ子通信 #おたよりドスラヂ #荒山セントラル郵便局 #ナイトグロウ さん #蒼いプラズマ さん #ドスラヂ2605

AbstractThis article explores the often-overlooked tragedy of promising happiness through overcoming disability. It draws on qualitative interviews and focus groups with 36 adults with cerebral palsy to explore how medical discourse shapes the ways in which individuals are encouraged to pursue a good life, leading to unintended consequences. Sara Ahmed's theory of happiness is used to understand the dialectics of pursuing a good life through overcoming disability, revealing how medical interventions and discourse during childhood inadvertently contribute to feelings of inferiority and social alienation. The article highlights the need to reconsider how individuals with disabilities are encouraged to pursue a good life, emphasizing the paradox of disabling effects arising from attempts to minimize and overcome disability.https://www.sciencedirect.com/science/article/pii/S027795362500098X

The guys are joined by special guest Mr. McKlunkey to discuss QOL updates, 3v3 Grand Arena, whether Egnards ruined SWGOH, Basement renovation, and How to farm Mods all in this weeks jam packed episode!

It is a narrower number of passionate people who are involved in all the activities that eventually make wine for you to enjoy. Todd Anderson will install posts and training wire, drive a tractor, watch the grapes grow, harvest, encourage the magic that transforms juice into wine... all this and more. He delights in taking you on the journey that opens your mind to experiences and vocabulary that express your delight in what you drink, taste... smell. Come along and learn from someone who has more than 5 decades in the world of wine; he has lots to share. Bet he will be back a guest of QOL in years to come!

In episode 110 of the Medical Nursing Podcast we're sitting down and talking about something we're often afraid to mention - and that's quality of life.  Not end of life, not euthanasia, but quality of life. An often misunderstood term, and one we need to normalise. Because the truth is, quality of life is the ultimate goal every single one of us have for every single one of our patients, every day. We make a bigger difference to it than you realise, and the evidence to back that up is VERY clear. So we are going to get into the evidence today. We're going to look at what the research really says about which factors most influence quality of life in our patients with chronic conditions, whether that's diabetes, CKD, osteoarthritis, chronic enteropathy, or other long-term diseases. And we're going to explore how we, as veterinary nurses and technicians, can make a difference to this. Resources mentioned this episode:

Is it possible? Did I meet Rob Straughan 13 years ago? Rob is the GM of radio station 96.7FM... it goes by the call sign CKLU. This station has hosted the original "Eat This! Drink That!" which morphed in the current program. QOL now deals with all the many things that fall under the umbrella of Quality of Life. In this episode Rob and I reminisce on the early days of the radio station; its origins as a smaller closed-circuit system for the university campus, followed by applications for a broadcast signal. There is lots of laughter, but also some ambient sound that you may become aware of. Recorded on a very windy day the whistling and impact of a storm can be heard. I hope it wont impact you enjoyment too much.

Hey everyone,I've done some more editing on our podcast video - hope it comes out good.Vik and I sat down to discuss 12 important points of the new 11th edition reveals.We're happy to see codexes roll onto 11th, and we think that means the datasheets will stay basically the same. The new detachments (70) leave a lot of room for inbalance, and we're curious to see how all this new game content will interplay with the new scoring mechanisms that are impacted by your faction of choice.Terrain and objective markers, David is not a huge fan but Vik is, what's your thoughts on this?The fight phase has been a mess for more-or-less all of 10th edition, with some large changes coming, what do you think the fight phase could look like now, are the charge changes a nice QOL? Will the new 'pile in at once' mechanics prevent players from having good combat phases?Enjoy,Vik and David

On this week's episode of the Massively OP Podcast, Bree and Justin talk about World of Warcraft: Midnight's official launch, AdventureQuest Worlds' big Kickstarter pull, and patches for LOTRO and Elder Scrolls Online. Note that this is a shorter podcast than normal due to a glitch losing a big chunk of our audio! It's the Massively OP Podcast, an action-packed hour of news, tales, opinions, and gamer emails! And remember, if you'd like to send in your question to the show, use this link. Show notes: Intro Adventures in MMOs: WoW Classic, World of Warcraft, LOTRO AdventureQuest Worlds pulls in huge crowdfunding numbers Lord of the Rings Online's Update 47 arrives ESO drops a huge QoL update This is where the podcast drops out, sorry about the missing chunk! Outro Other info: Podcast theme: "Code Race" from Marathon Your show hosts: Justin and Bree Listen to Massively OP Podcast on iTunes, Stitcher, Player FM, TuneIn, iHeartRadio, Pocket Casts, Amazon, and Spotify Follow Massively Overpowered: Website, Twitter, Facebook, Twitch If you're having problems seeing or using the web player, please check your flashblock or scriptblock setting.

◆Voicy新チャンネル開設！【獣医Sara先生のペットの暮らしと健康】 https://bit.ly/3sLljup＜Standfm メンバーシップ：メンバーになりませんか？＞【ペットのホリスティックケアCLUB】みんなでギネス長寿記録を目指す！５つの特典アリ！【人もペットも一緒に健康で長生きしよう】プロジェクト始動！ https://bit.ly/3BL0dgr＜本日のおすすめStandfm＞＝尊厳死とペットロスシリーズ＝◆第137回：強制給餌はするべき？（ペットロスにならないために考えた方が良いこと） https://bit.ly/3W500Av◆第183回：死別のとき、後悔しない選択をするためには？（ペットロスなど） https://bit.ly/3OamBJZ◆第514回：ペットロスと飼い主さんのメンタルは繋がっている https://bit.ly/3M2TeGP◆第532回：尊厳死について獣医さんが語る：イギリスではおススメされていない処置 https://bit.ly/3Bo1bkO◆第586回：コラボ対談：いっぺん死んでみる講師＆獣医師みどり先生とペットロス https://bit.ly/42AVTi4◆第814回：重要：手術するべきか、安楽死するべきか？（質問に回答） https://tinyurl.com/4ukun67m◆第825回：動物にも尊厳死を：ペットロスを迎える全ての方へお伝えしたいこと https://tinyurl.com/29cycx4z◆第875回：ペットロスから立ち直る方法６つ https://tinyurl.com/2k42ntf6◆第877回：激辛：ペットロスの人に言ってはいけない発言５つ https://tinyurl.com/3uv6nf85◆内科医たけお先生とコラボ

Lured Up Podcast 384 - The Scopely Effect Live Streamed on -2/24/26 Publish Date - 2/27/26 Happy Pokémon Day! This episode is releasing on a very important day, and we hope everyone has an excellent time. Niantic has given us an incredible amount of information, not just about events, but about the new Season and some significant changes that are coming! We start with a recap of the last week of gameplay including The Lunar New Year Event and the kickoff to the Road to Kalos. If you have been feeling like things have been building towards something, you have been feeling correctly. We will be seeing major changes to event and scheduling structures, a move away from event tickets to GO Passes, and some fun QOL updates like the ability to catch evolved form Shinies in the wild. Memories In Motion will be the potential dawn of a new era, with all of the announcements kicking off with the start of the new season. ITL Kalos Tour gave us a preview of the new Mega System. Link Charges have caused a stir online, however we feel strongly that they are a massive win for Trainers as a no cost option to Raid.  The March Content Update has been met with mixed reviews. Niantic's new strategy seems to give us even less news than before, which was already a sore spot. With the top secret debut of Mega Dragonite, it does feel good to be pleasantly surprised.This all feels very calculated, and we will keep a close eye on it over the Season. Our final discussion takes a macro look at the upcoming changes. For better or worse, the Scopely Effect is beginning to take shape. Is the Community ready to embrace the change, or will they form a resistance? Time will tell, and we are exceptionally here for it all. Lunar New Year Road To Kalos Early Bonus Road To Kalos New Mega System Memories In Motion March Content Update Scorbunny Community Day Stay up to date by adding our Google Calendar to your account! LuredUp@PokemonProfessor.com     Voicemail and SMS: 732-835-8639  Grab some merch: https://crowdmade.com/collections/professornetwork  Connect with us on multiple platforms! https://linktr.ee/PokemonProfessorNetwork  Hosts Ken Pescatore Adam Tuttle Writer and Producer Ken Pescatore Executive Producer  Xander Show music provided by GameChops and licensed through Creative Commons ▾ FOLLOW GAMECHOPS ▾ http://instagram.com/GameChops http://twitter.com/GameChops http://soundcloud.com/GameChops http://facebook.com/GameChops http://youtube.com/GameChops http://www.gamechops.com Intro Music Lake Verity (Drum & Bass Remix)  Tetracase GameChops - Ultraball http://gamechops.com/ultraball/ https://soundcloud.com/tetracase  https://soundcloud.com/MegaFlare0 Break Music National Park Mikel & GameChops GameChops - Poké & Chill http://smarturl.it/pokechill https://twitter.com/mikel_beats Outro Music Vast Poni Canyon CG5 & GlitchxCity (Future Bass Remix) GameChops - Ultraball http://gamechops.com/ultraball/  http://soundcloud.com/cg5-beats https://soundcloud.com/glitchxcity Pokémon And All Respective Names are Trademark and © of Nintendo 1996-2025 Pokémon GO is Trademark and © of Niantic, Inc.Lured Up and the Pokémon Professor Network are not affiliated with Niantic Inc., The Pokémon Company, Game Freak or Nintendo. #pokemon #pokemongo #podcast Learn more about your ad choices. Visit podcastchoices.com/adchoices

Linktree: ⁠https://linktr.ee/Analytic⁠Join The Normandy For Additional Bonus Audio And Visual Content For All Things Nme+! Join Here: ⁠https://ow.ly/msoH50WCu0K⁠Join Analytic Dreamz on the latest segment of Notorious Mass Effect for an in-depth analytical breakdown of Dragon Quest VII: Reimagined — the groundbreaking 2026 ground-up remake of the classic JRPG originally released as Dragon Quest VII: Fragments of the Forgotten Past (known in Japan as Warriors of Eden).This turn-based masterpiece, directed by Yuji Horii with iconic Akira Toriyama character designs and music by Koichi Sugiyama, returns transformed. Featuring stunning diorama-like handcrafted 3D environments and a doll-inspired aesthetic, the remake streamlines narrative pacing while overhauling combat and adding essential quality-of-life features like auto-battle, speed toggles, and field insta-kills for weak enemies.Dive into the core gameplay: collect stone tablet fragments to restore lost islands through time travel, exploring present and past versions with integrated puzzle-solving and town-building mechanics where you recruit NPCs to upgrade your hometown. The vocation system evolves with moonlighting (dual vocations) and "Let Loose" burst abilities, plus monster hearts for passive buffs and recruitment for a monster park (no direct party use). No multiplayer exists, but optional post-game superbosses await.Analytic Dreamz compares playtime metrics — main story now 40–50 hours (down from 100+ on PS1 and 75–80 on 3DS) — and covers the expanded content scope: 4–5 core party members (Hero/Auster, Kiefer, Maribel, Mervyn, Aishe), 20+ vocations from basics to advanced tiers, hundreds of monsters, 20+ major islands across dual timelines, side quests, casinos, and mini-games.The 2026 multiplatform launch (Nintendo Switch, Switch 2, PS5, Xbox Series X|S, PC) drove strong performance: ~457K physical units in Japan week 1 (Switch 178K, Switch 2 160K, PS5 119K), Steam peak at 27K concurrency, and a #4 UK debut — second-best franchise launch. Critics praise the visual overhaul, QoL improvements, and pacing (81–83 Metacritic, e.g., Nintendo Life 9/10), though some legacy fans debate story trimming and removed elements.Analytic Dreamz explores development by HexaDrive with Square Enix polishing, historical context from PS1 (4.1M worldwide) and 3DS versions, plus strategic takeaways: modernization prioritizes accessibility over maximal retention, broadening appeal beyond Japan's core market while dividing purists.Tune in for this comprehensive analysis of how Dragon Quest VII: Reimagined redefines a timeless epic for modern players.Support this podcast at — https://redcircle.com/analytic-dreamz-notorious-mass-effect/exclusive-contentPrivacy & Opt-Out: https://redcircle.com/privacy

Support my work on Patreon- https://patreon.com/realdavejackson Join the Tales from the Backlog Discord server- https://discord.gg/kAqSBb6jH2 Buy me a coffee on Ko-fi- https://ko-fi.com/realdavejackson Very few games have ever had the hype cycle that Hollow Knight: Silksong (Team Cherry, 2025) had, so the question remained once the game was finally released- did it live up to the hype? Clown masks and Nintendo Direct comment section explosions quickly gave way to Discourse surrounding Silksong's difficulty and sometimes anti-QoL approach. So was the juice worth the squeeze? Listen in to find out. Guest info: Jenny Windom (she/her) Check out Geeks & Grounds podcast https://www.geeksandgrounds.com/ Check out Jenny's YouTube channel https://www.youtube.com/kimchica TIMESTAMPS 0:00 Title Card 0:13 Introductions 9:06 Our Histories with Hollow Knight and Silksong 12:45 Opening Thoughts about Silksong 18:26 Difficulty and Accessibility 23:19 Story Setup and Visuals 27:31 The Pilgrimage, Characters and Voice Acting 36:25 The Pilgrimage and Anti-QoL Design 48:29 Challenge Ramp-Up and Difficulty Curve 57:53 Silksong- A Good Teacher & Overcoming Challenge 1:05:47 Metroidvania Design, Visuals and Music 1:14:18 Boss Fights, Combat Challenges and Runbacks 1:33:42 Crests, Tools, Customization 1:40:40 Closing Thoughts/Recommendations 1:45:54 Geeks & Grounds and Jenny's Other Work 1:51:22 Spoiler Wall and Patron Thank-Yous 1:53:13 Spoiler Section- Favorite Boss Fights 2:18:22 Spoiler Section- The Citadel and Faith 2:27:46 Spoiler Section- Hornet's Growth, Sherma and Community 2:45:23 Spoiler Section- Motherhood and Endings Music used in the episode is credited to Christopher Larkin. Tracks used: Silksong, Bone Bottom, Trobbio, Cogwork Dancers, Bilewater, Far Fields, Lost Lace, Fleatopia Social Media: BlueSky- https://bsky.app/profile/tftblpod.bsky.social Instagram- https://www.instagram.com/talesfromthebacklog/ Cover art by Jack Allen- find him at https://linktr.ee/JackAllenCaricatures

The first big blog of 2026 was (in Michaels words) a HEATER! Lots of pretty neat QOL coming to the game, both polled and unpolled. Get pumped! Community Question: If you could combine two items to create a functional fashionscape item, what would you combine?

This week’s Pulm PEEPs Pearls episode is a focused discussion between Furf and Monty about non-pharmacologic techniques for airway clearance in the non-Cystic Fibrosis bronchiectasis population. This is a focused, high-yield discussion of the key points about airway clearance, including practical tips and a discussion of the evidence. This episode was prepared in conjunction with George Doumat MD. Goerge is an internal medicine resident at UT Southwestern and joined us for a Pulm PEEPs – BMJ Thorax journal club episode. He is now acting as a Pulm PEEPs Editor for the Pulm PEEPs Pearls series. Key Learning Points 1) Why airway clearance matters in non-CF bronchiectasis Non-CF bronchiectasis is defined by irreversible bronchial dilation with impaired mucociliary clearance, leading to mucus retention. Retained sputum drives the classic vicious cycle: mucus → infection → neutrophilic inflammation → airway damage → worse clearance. Airway clearance techniques (ACTs) are meant to interrupt this cycle, primarily by improving mucus mobilization and symptom control. 2) What ACTs are trying to achieve clinically Main benefits are: More effective sputum clearance Reduced cough/dyspnea burden Improved activity tolerance and quality of life Effects on spirometry are usually small. Exacerbation reduction is possible, but evidence is mixed—some longer-term data suggest benefit for specific techniques. 3) The main ACT “families” and when to use them Breathing-based techniques (device-free, flexible) ACBT (Active Cycle of Breathing Technique): breath control → deep breaths with holds → huffing. Pros: portable, adaptable, good first-line option. Key requirement: teaching/coaching to get technique right. Autogenic drainage: controlled breathing at different lung volumes to move mucus from peripheral → central airways. Pros: no device, can work well once learned. Cons: more technically demanding, needs training and practice. PEP / Oscillatory PEP (stents airways + “vibrates” mucus loose) PEP: back-pressure helps prevent small airway collapse during exhalation; often paired with huff/cough. Oscillatory PEP (Flutter/Acapella/Aerobika): adds oscillation that many patients find easy and satisfying to use. Good fit for: people who benefit from airway stenting, want something portable, and prefer a device. Mechanical/manual techniques (help when patient can't self-clear well) HFCWO (“the vest”): external chest wall oscillation; helpful for high sputum volumes, dexterity limits, or difficulty coordinating breathing maneuvers. Postural drainage/percussion/vibration: caregiver/therapist-assisted options; still useful but consider: GERD/reflux risk with certain positions Hemoptysis risk with vigorous techniques 4) How to choose the “right” technique (the practical framework) There is no one-size-fits-all. Match the tool to the patient: Sputum burden (volume/viscosity) Strength, coordination, cognition, dexterity Comorbidities (GERD, hemoptysis history, severe obstruction/airway collapse) Lifestyle + portability (what they'll actually do) Cost/access and availability of respiratory therapy/physio support A key mindset from the script: this is not a lifetime contract—reassess and adjust over time with shared decision-making. 5) Evidence takeaways (what improves, what doesn't) ACTs reliably improve sputum expectoration and often symptoms/QoL. QoL/cough scores (e.g., SGRQ, LCQ) tend to improve modestly, particularly with oscillatory PEP and some vest studies. Lung function: typically minimal change; occasional short-term FEV₁ benefit is reported in some vest trials. Exacerbations: mixed overall; the script highlights a longer-term RCT of ELTGOL showing fewer exacerbations at 12 months vs placebo exercises. Safety: generally excellent; main cautions are hemoptysis and reflux (depending on technique/positioning). 6) Special population pearls Hemoptysis / fragile airways: start with gentle breathing-based ACTs (ACBT, controlled huffing); avoid overly vigorous oscillatory/manual methods if concerned. Severe obstruction or early airway collapse: PEP/oscillatory PEP can help by keeping small airways open on exhalation. Mobility/coordination barriers: consider HFCWO vest or simple oscillatory PEP devices to enable daily adherence. During exacerbations: keep it simple—1–2 reliable techniques, prioritize daily consistency, and re-check technique. 7) The “real” bottom line Start with simple, self-manageable options (often ACBT ± PEP). The “best” ACT is the one the patient will do consistently. Reassess technique and fit over time; education and demonstration are part of the therapy. References and Further Reading  Lee AL et al., “Airway clearance techniques for bronchiectasis,” Cochrane Database Syst Rev. 2015; PMC7175838. PMID: 26591003. Athanazio RA et al., “Airway Clearance Techniques in Bronchiectasis,” Front Med (Lausanne). 2020; PMC7674976. PMID: 33251032. Iacono R et al., “Mucociliary clearance techniques for treating non-cystic fibrosis bronchiectasis,” Eur Rev Med Pharmacol Sci. 2015; PMID: 26078380. Polverino E et al., “European Respiratory Society statement on airway clearance techniques in bronchiectasis,” Eur Respir J. 2023; PMID: 37142337. Doumat G, Aksamit TR, Kanj AN. Bronchiectasis: A clinical review of inflammation. Respir Med. 2025 Aug;244:108179. doi: 10.1016/j.rmed.2025.108179. Epub 2025 May 25. PMID: 40425105.

Dr. Kendra Coulter is the author of  Defending Animals. I read an article in the Globe and Mail and just had to have a conversation with her here on QOL . Coulter is a Professor of Management and Organizational Studies, at Huron University College at Western. She is a Fellow of the Oxford Centre for Animal Ethics, and Member, Royal Society of Canada's College of New Scholars, Artists, and Scientists.This program is being re-released to stimulate additional awareness of abuse and neglect of all animals.Though specific reference to Marineland is not made, there are responsibilities we have towards all captive animals.

00:49 – Show open, holiday greetings, and massive live server sound-off 06:29 – Festivus, Diwali, Yule, and “everyone is included” holiday chaos 09:55 – Return of Stupid News and podcast throwback energy 10:40 – Christopher Nolan's The Odyssey and pop-culture headlines 12:40 – Cruise culture jokes, Disney controversy, and odd news reactions 15:32 – Audience reactions and grading the return of Stupid News 16:45 – Jules Verne joins the stage for a major community announcement 18:12 – Jules Verne officially announced for Star Trek Cruise IX (face reveal!) 19:40 – Talking Trek creator lineup revealed for the 2026 cruise 21:12 – Cape Canaveral meetup details, free tickets, and community plans 23:59 – Cruise meetups, swag, giveaways, and Scopely proximity jokes 25:00 – Cruise production upgrades, multi-camera streaming, and backpack tech discussion 27:15 – Streaming quality upgrades: 1080p60, bitrate increases, and Twitch limits 28:02 – Cruise panel restrictions, permissions, and appeal process explained 30:02 – Jules Verne impact on the community and long-term influence discussion 31:55 – Griffin exits; transition from announcements into year-end reflection 32:45 – Setting the tone for the 2025 retrospective and honest assessment 34:55 – Framing the discussion: best features, officers, and QoL of 2025 36:35 – G7 launch and regional/Veil space as a major gameplay shift 38:55 – Claim-All refinery button praised as top QoL improvement 41:05 – Squall ship impact across G5–G7 progression and loop value 44:40 – Evergreen officer discussion: Joaquin (Wrath of Khan) breakdown 48:30 – Regional chat, server interaction, and MMO identity finally realized 53:10 – Panel consensus, chat feedback, and comparative perspective vs 2024 58:20 – Wrapping the first hour: momentum, lessons learned, and tone shift 01:02:00 – Transition into 2025 year-in-review discussion 01:08:30 – Honest reflection: was 2025 better than 2024 for STFC? 01:15:20 – G7 launch, Veil space, and regional chat impact 01:21:45 – Joaquin (Wrath of Khan) and evergreen officer design discussion 01:28:40 – Claim-All button praised as best QoL improvement of the year 01:36:10 – Squall ship breakdown and why the loop still matters 01:52:30 – Regional gameplay, Veil chat interactions, and community scale 02:18:40 – Panel feedback, chat consensus, and feature prioritization 02:47:55 – Final thoughts on 2025 progress, lessons learned, and momentum

Today, Dave Furfaro, Luke Hedrick, and Robert Wharton discuss the PREDMETH trial published in The New England Journal of Medicine in 2025. This was a non-inferiority trial comparing prednisone to methotrexate for upfront therapy in treatment-naive sarcoidosis patients. Listen in for a break down of the trial, analysis, and clinically applicable pearls. Article and Reference Todays’ episode discusses the PREDMETH trial published in NEJM in 2025. Kahlmann V, Janssen Bonás M, Moor CC, Grutters JC, Mostard RLM, van Rijswijk HNAJ, van der Maten J, Marges ER, Moonen LAA, Overbeek MJ, Koopman B, Loth DW, Nossent EJ, Wagenaar M, Kramer H, Wielders PLML, Bonta PI, Walen S, Bogaarts BAHA, Kerstens R, Overgaauw M, Veltkamp M, Wijsenbeek MS; PREDMETH Collaborators. First-Line Treatment of Pulmonary Sarcoidosis with Prednisone or Methotrexate. N Engl J Med. 2025 Jul 17;393(3):231-242. doi: 10.1056/NEJMoa2501443. Epub 2025 May 18. PMID: 40387020. https://www.nejm.org/doi/full/10.1056/NEJMoa2501443 Meet Our Hosts Luke Hedrick is an Associate Editor at Pulm PEEPs and runs the Rapid Fire Journal Club Series. He is a senior PCCM fellow at Emory, and will be starting as a pulmonary attending at Duke University next year. Robert Wharton is a recurring guest on Pulm PEEPs as a part of our Rapid Fire Journal Club Series. He completed his internal medicine residency at Mt. Sinai in New York City, and is currently a first year pulmonary and critical care fellow at Johns Hopkins. Key Learning Points Clinical context Prednisone remains the traditional first-line treatment for pulmonary sarcoidosis when treatment is indicated, with evidence for short-term improvements in symptoms, radiographic findings, and pulmonary function—but with substantial, familiar steroid toxicities (weight gain, insomnia, HTN/DM, infection risk, etc.). Despite widespread use, glucocorticoids haven't been robustly tested head-to-head against many alternatives as initial therapy, and evidence for preventing long-term decline (especially in severe disease) is limited. Immunosuppressants (like methotrexate) are often used as steroid-sparing agents, but guideline recommendations are generally conditional/low-quality evidence, and practice varies. Why PREDMETH matters It addresses a real-world question: Can methotrexate be an initial alternative to prednisone in pulmonary sarcoidosis, rather than being reserved only for steroid-sparing later? It also probes a common clinical belief: MTX has slower onset than prednisone (often assumed, not well-proven). Trial design (what to know) Open-label, randomized, noninferiority trial across 17 hospitals in the Netherlands. Included patients with pulmonary sarcoidosis who had a clear pulmonary indication to start systemic therapy (moderate/severe symptoms plus objective risk features like reduced FVC/DLCO or documented decline, plus parenchymal abnormalities). Excluded: non–treatment-naïve patients and those whose primary indication was extrapulmonary disease. Treat-to-tolerability with escalation: both drugs started low and were slowly increased; switch/add-on allowed for inadequate efficacy or unacceptable side effects. Primary endpoint: change in FVC (with the usual caveat that FVC is “objective-ish,” but effort-dependent and not always patient-centered). Noninferiority margin: 5% FVC, justified as within biologic/measurement variation and “not clinically relevant.” Outcomes assessed at weeks 4, 16, 24; powered for ~110 patients to detect the NI margin. Patient population (who this applies to) Mostly middle-aged (~40s) with mild-to-moderate physiologic impairment on average (FVC ~77% predicted; DLCO ~70% predicted). Netherlands-based cohort with limited Black representation (~7%), which matters for generalizability. Would have been helpful to know more about comorbidities (e.g., diabetes), which can strongly influence prednisone risk. Main findings (what happened) Methotrexate was noninferior to prednisone at week 24 for FVC: Between-group difference in least-squares mean change at week 24: −1.17 percentage points (favoring prednisone) with CI −4.27 to +1.93, staying within the 5% NI margin. Timing mattered: Prednisone showed earlier benefit (notably by week 4) in FVC and across quality-of-life measures. By week 24, those early differences largely washed out—possibly because MTX “catches up,” and/or because crossover increased over time. In their reporting, MTX didn't meet noninferiority for FVC until week 24, supporting the practical message that prednisone works faster. Crossover and analysis nuance (important for interpretation) Crossover was fairly high, which complicates noninferiority interpretation: MTX arm: some switched to prednisone for adverse events and others had prednisone added for disease progression/persistent symptoms. Prednisone arm: some had MTX added. In noninferiority trials, heavy crossover can bias intention-to-treat analyses toward finding “no difference” (making noninferiority easier to claim). Per-protocol analyses avoid some of that but introduce other biases. They reported both. Safety signals (what to remember clinically) Adverse events were very common in both arms (almost everyone), mostly mild. Side-effect patterns fit expectations: Prednisone: more insomnia (and classic steroid issues). MTX: more headache/cough/rash, and notably liver enzyme elevations (about 1 in 4), with a small number discontinuing. Serious adverse events were rare; numbers were too small to confidently separate “signal vs noise,” but overall known risk profiles apply. Limitations (why you shouldn't over-read it) Open-label design, and FVC—while objective-ish—is still effort-dependent and can be influenced by expectation/behavior. Small trial, limiting subgroup conclusions (e.g., severity strata, different phenotypes). Generalizability issues (Netherlands demographics; US populations have higher rates of obesity/metabolic syndrome, which may tilt the steroid risk-benefit equation). Crossover reduces precision and interpretability of between-group differences over time. Practice implications (the “so what”) For many patients with pulmonary sarcoidosis needing systemic therapy, MTX is a reasonable initial alternative to prednisone when thinking long-term tolerability and steroid avoidance. Prednisone likely provides faster symptom/QoL relief in the first weeks—so it may be preferable when rapid improvement is important. The trial strengthens the case for a patient-centered discussion: short-term relief vs side-effect tradeoffs, and the possibility of early combination therapy in more severe cases (suggested, not proven).

What makes Godforge fun — and why do players care so much already? This episode dives into community feedback, design changes, QoL improvements, events, and the philosophy behind building trust in a live game. Fateless is a dynamic game studio founded by passionate content creators Simon Lockerby (Hellhades), Dan Francis (Phixion), and Hisham Saleh (Sham). Our mission is to create community-driven, immersive RPG Hero Collector games that emphasize player agency, storytelling, and strategic gameplay. Join us as we share our journey from concept to launch and beyond.Support the show

Welcome to Episode 268 of BORN TO BE WILD, a Wild exclusive Hearthstone podcast where we have fun hanging out with friends, talking about the Wild format of Hearthstone and spotlighting members of the Wild Community!This week ElectricSheepCity, Hydralisk, and Schmoopiedady discuss our weeks, the news, and the many smooth quality of life (QoL) improvements.0:00 Welcome0:57 Housekeeping2:23 How Was Your Week?40:45 News1:41:14 Unrelated AdviceShow Notes: https://docs.google.com/document/d/1cyIS7C6uvs9Xf1YF0qmQUmKMusEQQmb4LrU3vaSvWO0/

I started reading posts by Debbie Rosaline on LinkedIn. Was it pre-COVID? She definitely had insights and aligned with thoughts I too had about the wine and hospitality industry. She also wrote about luxury brands and high-touch service, so I thought she would be an ideal guest here on QOL. We set a date to talk. I think we will have more conversations. Join us here on this episode and follow her journey of discovery of Canadian wines, wines of the world, and the changes and challenges facing the industry globaly.

What obvious joke? 0:00 - I'm no longer posting on Twitter. Find me at Bluesky (link below) 0:50 - Anther year, another wildly successful Extra Life marathon! 7:57 - San Diego Gas & Electric sent me a survey. It was poorly written and I told them so. 15:18 - I work in the education system. We were hit with layoffs. It sucks. 24:07 - GTA VI was delayed again. Surprise! 37:09 - Monster Hunter Wilds has no interest in America's dumb insistence on continuing with Daylight Savings. 42:01 - I've been playing the Trails In the Sky remake. Here are my thoughts thus far. If you missed Saturday's live broadcast of Molehill Mountain, you can watch the video replay on YouTube.  Alternatively, you can catch audio versions of the show on iTunes. Molehill Mountain streams live at 7p PST every Saturday night! Credits: Molehill Mountain is hosted by Andrew Eisen.  Music in the show includes "To the Top" by Silent Partner.  It is in the public domain and free to use.  Molehill Mountain logo by Scott Hepting. Chat Transcript: 6:58 PM@eathdemon​​hows ewcovering from extra life going 6:59 PM@artoflynndylee​​hello 7:00 PM@Zeronautic​​There's still time to wear the Extra Life marathon chain necklace! 7:05 PM@Zeronautic​​Your Extra Life stream is always one of my favorite days of the year. It's incredibly fun -- but it's also hugely inspiring, and a beacon of positivity when life can be bleak 7:30 PM@LeeShowrons​​Hey 7:40 PM@Sheekago​​Hey Andrew and everyone 7:41 PM@atchaos4life​​Hi all 7:46 PM@addictedtochaos2​​Such a helpful feature 7:49 PM@Sheekago​​Would Trails in the Sky FC Remake be a good starting chapter for a person trying to get into the series? Would it be better to start with the original? 7:51 PM@Sheekago​​I'm playing Persona 3 Portable and enjoying it. I'm probably around your age. 7:52 PM@Sheekago​​I do prefer QOL updates and better graphics, but not opposed to older games. 7:54 PM@jaredknisely6213​​its very weak 7:54 PM@jaredknisely6213​​im pretty sure they used ai for some stuff 7:54 PM@Sheekago​​My big hesitation is that it's a long series. I also take a very long time to beat games. 7:58 PM@Sheekago​​Okay, that is immersion breaking. I can understand not always having characters being voiced, but not one being voiced and the other not. 8:00 PM@addictedtochaos2​​Worst voice acting has to be Arc Rise Fantasia 8:14 PM@jaredknisely6213​​the pretzel farm 2nd quest is not in the original theere are several vita quests not in the original 8:14 PM@Sheekago​​Have a good night all

#309th  for 5th November, 2025 or 3311! (33-Oh-Leven, not Oh-Eleven, OH-Leven)http://loosescrewsed.comJoin us on discord! And check out the merch store! PROMO CODEShttps://discord.gg/3Vfap47ReaSupport us on Patreon: https://www.patreon.com/LooseScrewsEDSquad Update:  (Updated by Bloom 10/16)Busted in old and fun ways. Come join us colonizing, BGS works out here.Ish. So does the colonizingPowerPlay Update: - (unashamedly copied from KrugerFive's post in our Discord, 10/30)Cycle 52: we are 1 day ahead of the cycle so… no updateKruger 5's Power Rankings - https://k5elite.com/ Niceygy's Power Points - https://elite.niceygy.net/powerpointsFind out more in the LSN-powerplay-hub forum channel.Dev News: Elite Dangerous | Developer Log - 4 November 2025Galnet News: https://community.elitedangerous.com/ (updated 10/23)Trailblazer Fleet To Be WithdrawnDiscussion:New Video StyleTrailblazers out of beta on 11 November Significant amount of fixes and QoL to BGS, PP, and ColonizationBalance pass for on-foot combatNew star port - Dodec station - Tier 3+ Available at the 11Nov updateTech broker, higher stats all around50k ARX to unlock per account, deploy one instantly where allowed, and then build others as normalNew ship - Zorgon Caspian Explorer - early access in DecemberLarge padCan load mk2 modulesIncluding new MK2 FSD with improved neutron superchargingRetracting engine bitsSmall landing footprintSaid something about “mind that gravity and spot interesting plating pattern on hull”New feature pushed to early 2026 - OperationsNew set of multi-phased scenariosOn foot and in space4 CMDRs take on a challenging obstacleNever seen before areas - internals of hostile megashipMultiple operations, varying difficultyRewards that are difficult to obtain

Follow, watch, and rate all of our podcasts on Spotify! https://open.spotify.com/show/1hXrn6RoMMAiNGLE8jxKKf Thank you for the support! Time Stamps - - Start - Housekeeping - ARC Raiders Review (So Far) - SuperChats - Onboarding, QoL, etc. - Missions - Roadmap & Longevity - SuperChats Unlisted YouTube - Learn more about your ad choices. Visit megaphone.fm/adchoices

Follow, watch, and rate all of our podcasts on Spotify! https://open.spotify.com/show/1hXrn6RoMMAiNGLE8jxKKf Thank you for the support! Time Stamps - - Start - Housekeeping - ARC Raiders Review (So Far) - SuperChats - Onboarding, QoL, etc. - Missions - Roadmap & Longevity - SuperChats Unlisted YouTube - Learn more about your ad choices. Visit megaphone.fm/adchoices

Follow, watch, and rate all of our podcasts on Spotify! https://open.spotify.com/show/1hXrn6RoMMAiNGLE8jxKKf Thank you for the support! Time Stamps - - Start - Housekeeping - ARC Raiders Review (So Far) - SuperChats - Onboarding, QoL, etc. - Missions - Roadmap & Longevity - SuperChats Unlisted YouTube - Learn more about your ad choices. Visit megaphone.fm/adchoices

Follow, watch, and rate all of our podcasts on Spotify! https://open.spotify.com/show/1hXrn6RoMMAiNGLE8jxKKf Thank you for the support! Time Stamps - - Start - Housekeeping - ARC Raiders Review (So Far) - SuperChats - Onboarding, QoL, etc. - Missions - Roadmap & Longevity - SuperChats Unlisted YouTube - Learn more about your ad choices. Visit megaphone.fm/adchoices

In episode 316 (final answer), we go back on our promises. GGG's newest Path of Exile 1 expansion, 3.27's Keepers of the Flame, has so many QoL improvements, revamped trade, sub ascendancies (Bloodlines), and so much more, that we may, kind of, sort of, possibly, might play more of the original game then we planned. Blast you, GGG! PoE 2 is on hold! Thanks for the great expansion, and thanks, everyone, for your listens each week!(00:00:00) Welcome to Forever Exiled(00:18:55) Private league recap and community thanks(00:23:42) Patch 3.27 reveal and GGG announcements(00:28:50) POE2 progress updates and MTX merges(00:35:30) Asynchronous trade finally arrives(00:40:05) Quality of life upgrades and stash changes(00:45:25) Breach league redesign and gameplay loop(00:51:00) Bloodlines pseudo-ascendancies discussion(00:54:45) Visual clarity, loot filters, and UI chaos(00:58:12) Minion accuracy removal and balance talk(01:01:50) POE1 vs POE2 coexistence and final thoughtsForever Exiled Info:www.foreverexiled.comPatreonTwitter @ForeverExiled82Path of Exile WebsiteWrecker of Days Builds ListDiscord...FE Merch StoreFE Nexus Store

In patients with heart failure, remote hemodynamic monitoring can identify health changes long before symptoms appear, contributing to slower disease progression, improved patient outcomes, and reduced rehospitalizations. Learn more about current and future technology that can support better patient health, and the role of nurses in patient education and monitoring. Guests: Linda Park, PhD, MS, FNP-BC, FAAN, FAHA, FPCNA, and Eryn Bryant, MSN, APRN-CNP, FPCNA.PCNA Heart Failure Tools: https://pcna.net/health-topics/heart-failure/Tele-HF study: https://www.jacc.org/doi/10.1016/j.jchf.2015.07.017 CHAMPION Trial (CMEMs after CRT): Pulmonary Artery Pressure-Guided Management of Patients With Heart Failure and Reduced Ejection Fraction https://www.acc.org/latest-in-cardiology/clinical-trials/2015/12/29/12/44/championJournal of American College of Cardiology paper, Remote Monitoring and Heart Failure Scientific Statement: https://www.jacc.org/doi/10.1016/j.jacc.2023.04.010 European Society of Cardiology consensus statement: https://doi.org/10.1093/eurheartjsupp/suae116BMAD trial: BMAD Trial: Wearable Remote Monitor Reduces Hospital Readmission Risk in HF Patients - American College of Cardiology: https://www.acc.org/Latest-in-Cardiology/Articles/2023/03/01/22/45/mon-830am-bmad-acc-2023 GUIDE-HF trial (CMEMS, Lancet): Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial - The Lancet: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01754-2/abstractESCAPE trial (using RHC / pulm art pressures to guide therapy during ADHF: Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial - PubMed: https://pubmed.ncbi.nlm.nih.gov/16204662/MONITOR-HF trial (improved QOL and functional status w/ CMEMs): Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial - The Lancet: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00923-6/abstract MONITOR-HF: Pulmonary artery pressure monitoring in chronic heart failure: effects across clinically relevant subgroups in the MONITOR-HF trial | European Heart Journal | Oxford Academic: https://academic.oup.com/eurheartj/article/45/32/2954/7668040MONITOR-HF (summary in ACC): Remote Hemodynamic Monitoring of Pulmonary Artery Pressures in Patients With Chronic Heart Failure - American College of Cardiology: https://www.acc.org/Latest-in-Cardiology/Clinical-Trials/2023/07/18/17/21/monitor-hfHeartLogic: HeartLogic Multisensor Algorithm Identifies Patients During Periods of Significantly Increased Risk of Heart Failure Events: https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.117.004669SCALE-HF-1 Trial (bodyport scale to predict worsening HF trends): Use of a Cardiac Scale to Predict Heart Failure Events: Design of SCALE-HF 1 | Circulation: Heart Failure: https://www.ahajournals.org/doi/10.1161/CIRCHEARTFAILURE.122.010012See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Send us a textWelcome to another episode of The Gamerheads Podcast! This week, we welcome our friend and PAX West roommate Jacob McCourt (Crossplay Conversations, Video Game Trivia) to talk Final Fantasy Tactics: The Ivalice Chronicles!We break down why this remaster is worth your time, from the job system and map design to strong voice work and smart QoL tweaks, with spoiler-free thoughts on themes and accessibility. Check out Video Game Trivia from PAX West 2024 with Roger from Gamerheads!https://www.youtube.com/watch?v=3y3-JQnzcFECheck out the Video Game Trivia Live from the Hopvine Pub in Seattle.https://www.youtube.com/watch?v=IVSwLPhrSasSupport the showHere are a few ways you can support Gamerheads!Leave us a review!Not only does your review help fellow gamers discover our podcast, but it also provides valuable insights for us as content creators. Your feedback serves as a compass, guiding us in crafting episodes that cater to your interests, addressing topics that matter to you, and enhancing your overall listening experience. Your words have the power to influence the direction of future episodes and ensure that we continue delivering content that captivates and engages. Review us on Goodpods! Review us on Apple Podcasts! Review us on Spotify! Join our Discord!In The Gamerheads Podcast Discord, you'll find a haven for lively discussions, where you can chat about the latest releases and share your gaming experiences with fellow gamers.Join our Patreon today https://www.patreon.com/gamerheadsFollow us on BlueSky: https://bsky.app/profile/gamerheadspodcast.comMusic: Jeff Dasler - Recus...

#302th for 18th of September, 2025 or 3311! (33-Oh-Leven, not Oh-Eleven, OH-Leven)http://loosescrewsed.comJoin us on discord! And check out the merch store! PROMO CODEShttps://discord.gg/3Vfap47ReaSupport us on Patreon: https://www.patreon.com/LooseScrewsEDSquad Update:  (Updated by Bloom 9/18)BGS is still broken -> Not a joke -> 4 conflicts pending, our victory in Juan resulted in control of Lyell Hub but not the system.We're in 303 systems, controlling 77Squadron Boards - (To be updated tonight)joiPowerPlay Update: - Cycle 46Alexandrinus, The Highway to Hel's next potential targets More in PowerPlay HubKruger 5's Power Rankings - https://k5elite.com/ Niceygy's Power Points - https://elite.niceygy.net/powerpointsFind out more in the LSN-powerplay-hub forum channel.Galnet Update: https://community.elitedangerous.com/Galnuthin'The Exploration CG has 11K contributors, 3 days left - 75% earns you a V1 DSS, just in time for your T11Dev News: Third tier - Galactic Edition announced - 60K buys you the ship, stellar paints, stellar ship kit, hazard ship kit, holo ship kit. Fixes for QOL stuff: The Organic Sampler scanning range is going to be adjusted from 75m → 750m  - Colonisation construction efforts and fully constructed facilities will be able to be demolished or cancelled- Colonisation commodities requirements will be listed when selecting the system on the Galaxy Map or selecting the facility on the System Map - Frontier are also introducing a new tool which will allow Commanders to change their name at a cost of 500 ARX. We currently do not have any other information or answers to the questions these new changes will bring in, but as always will keep you posted if we get more.Discussion:Community Corner:ROYS GAME???

Oh boy. It's here. Josh takes a solo dive into the Renegades reveal stream, the baffling QOL changes and... Ash and Iron. Let's Begin.Join the Discord and be part of the show!Follow Corey on Twitter, Instagram and Bluesky at @iamcoreyinhdFollow Josh on Twitter at @josh_finn

Guest: Forrest Smith — serial founder bringing clinic-grade photobiomodulation to a safe, wearable form factor. Theme: Why dose and delivery matter more than raw wattage for red light therapy.Key takeawaysWavelengths that work: Deep red 660 nm (blood flow, NO release, shallow penetration) + 808 nm near-IR (deeper tissues/joints).Mechanisms: Hemoglobin photodissociates NO → vasodilation + better O₂ delivery; mitochondria's cytochrome c oxidase bottleneck relieved → higher ATP output; downstream: resilience to oxidative stress.Performance & recovery: Overnight reductions in CK and CRP let athletes train sooner; UFC PI and USA Weightlifting use cases mentioned.Brains & microvessels: Near-IR protocols tied to BDNF and microvascular improvements—an emerging Alzheimer's angle.Dosing > device hype: Class-1 lasers allow precise, reproducible dosing to deeper targets; panels/LEDs spread light too broadly and shift dose by distance (inverse-square).Safety & contraindications: Class-1 lasers are eye-safe in normal use; titanium implants OK (osseointegration may improve). Pregnancy and active cancer: regulatory contraindications despite encouraging early data.Personal protocol (example): 15 min over carotids + 15 min lower abdomen (gut) upon waking; higher-melanin skin generally needs longer time at same power.Resources & links (from interview)Kineon: kineon.io Chapter markers (approx.)00:00 Why red light now? 00:34 Mission: measurable QoL at scale 03:02 Risks of NSAIDs vs alternatives 03:34 660 nm + 808 nm explained 05:34 Newer NIR bands (905–1064 nm) 07:39 Penetration depth: red vs NIR 08:34 Photoacceptors & evolution (melanin) 10:28 Hemoglobin, NO, and O₂ delivery 12:02 Mitochondria & ATP bottleneck 14:06 Brain protection & TBI athletes 14:34 CK/CRP drops & faster training 15:55 Dosing by melanin level 17:49 Implants, pregnancy, cancer notes 21:22 Biphasic dose curve; laser classes 25:26 LEDs vs lasers; panels' dose drift 27:50 Strongest evidence areas (wound, knee OA) 29:33 Gut–brain, BDNF, microvasc/Alzheimer's 31:46 Forrest's daily protocol (neck + gut) 34:00 Systemic effects; fertilLies I Taught In Medical School : Free sample chapter- https://www.robertlufkinmd.com/lies/Complete Metabolic Heart Scan (LUFKIN20 for 20% off) https://www.innerscopic.com/Fasting Mimicking Diet (20% off) https://prolonlife.com/Lufkin At home blood testing (20% off) https://siphoxhealth.com/lufkinMimio Health (LUFKIN for 15% off) https://mimiohealth.sjv.io/c/5810114/2745519/30611 Web: https://robertlufkinmd.com/X: https://x.com/robertlufkinmdYoutube: https://www.youtube.com/robertLufkinmdInstagram: https://www.instagram.com/robertlufkinmd/LinkedIn: https://www.linkedin.com/in/robertlufkinmd/TikTok: https://www.tiktok.com/@robertlufkinThreads: https://www.threads.net/@robertlufkinmdFacebook: ...

Yes you can. Capital Games released one of the most comprehensive QoL imporvements in years in this latest update. And we were on break. We cover the new character progression system as well as one of the new characters to hit the holotables, Kix. Presented by Radio Free Tatooine (https://www.radiofreetatooine.com) We love hearing from our […] The post Galactic War Report – Episode 439: Can I Kix It? appeared first on RADIO FREE TATOOINE.

Jagex is back at again with some amazing QOL changes coming to our favorite point-and-click MMO! Another summer of sweep will be headed to an Old School Runescape server near you in the coming weeks, and we want to get you ready for it. Community Question: what does your most ideal blocklist look like?

For more information regarding this CME/CE activity and to complete the CME/CE requirements and claim credit for this activity, visit:https://www.mycme.com/courses/answers-in-chronic-spontaneous-urticaria-10190SummaryIn this short CE/CME activity, moderator Dr. Brad Glick works with dermatology expert Dr. Gil Yosipovitch to answer your top questions regarding chronic spontaneous urticaria, as gathered from the 2025 NACE Conversations in Dermatology symposium. Questions cover diagnosis, treatment individualization, and more!Learning ObjectivesAt the conclusion of this activity, participants should be better able to:Assess the disease burden and impact on QoL in patients with CSUEvaluate current and emerging therapies for CSUThis activity is accredited for CME/CE CreditThe National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.The National Association for Continuing Education designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.The National Association for Continuing Education is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 121222. This activity is approved for 0.25 contact hours (which includes 0.25 hours of pharmacology).For additional information about the accreditation of this program, please contact NACE at info@naceonline.com.Summary of Individual DisclosuresPlease review faculty and planner disclosures here.Disclosure of Commercial SupportThis activity is supported by an independent educational grant from Sanofi and Regeneron Pharmaceuticals.Please visit http://naceonline.com to engage in more live and on demand CME/CE content.

Clash Bashing joins to discuss everything in the June Update. Support the man by using code BASH in the shops.Links:Clash Bashing on YouTubeCompetitive Clash Network Discord (For Esports Everything)We're part of Supercell's Creators Program; find more information here: https://creators.supercell.com/en/supercell-partner Timestamps:(00:00) Intro and Happy Father's Day(02:10) Crafting Station(25:30) Ice Block DE Spell(31:51) New Levels(40:39) Cookbook(48:44) QoL, Bug Fixes, and Misc(56:44) Listener Questions

Jagex just dropped a MASSIVE blog full of amazing QOL updates that we are very excited for! Dont have time to read through it? Thats fine, we got you covered. Sit back and enjoy as we go through this blog and give you our thoughts. Community Question: If you could change the drop table of any boss in the game, to either make it totally busted....or more balanced, how would it change?

It's episode 295! That means...nothing! BUT, GGG had a great interview with Talkative Tri this week and we gleaned a bunch of information for both the future of Path of Exile 1 and PoE 2! With our private league coming to a close and GGG teasers, we hope you had a great Path of Exile week! Thank you, as always, for your listens each and every week. We love your faces!(00:00:00) Welcome to Forever Exiled and episode intro(00:00:27) Shoutout to our patrons(00:01:23) How was your week?(00:05:11) Neck issues and manual labour(00:09:30) Sleeping, stretching, and healing(00:11:30) Path of Exile begins(00:19:07) Getting crafts in PoE 2(00:24:15) POE1 burnout and switching to PoE 2(00:28:40) Storytelling in PoE 2 vs PoE 1(00:34:18) Big changes in the next PoE 2 patch(00:40:02) Passive tree and character building(00:46:10) PoE 2 lab discussion(00:51:00) Auto tree points and lab QoL(00:56:28) PoE 1 stash tabs and UI suggestions(01:00:43) Final thoughts and wrap upForever Exiled Info:www.foreverexiled.comPatreonTwitter @ForeverExiled82Path of Exile WebsiteWrecker of Days Builds ListDiscord...FE Merch StoreFE Nexus Store

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: Tandem's new infusion set is approved, Dexcom G7 compatibility with the Omnipod 5 iPhone app announced, Sernova cell-pouch moves forward, GLP-1 meds for T1D, and more! Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom   Check out VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX Tandem gets FDA clearance for a new infusion set. The company shared in an SEC filing that its Capillary Biomedical (CapBio) subsidiary won clearance for its SteadiSet Infusion Set. SteadiSet features an integrated inserter with a hidden needle designed for one-handed insertion. It received clearance to deliver insulin for up to three days of use. However, Tandem plans to submit a separate request to extend the indicated use time to up to seven days. It doesn't expect to begin commercial activities for SteadiSet until after it receives clearance for the extended use time. Many of us have been following this since Tandem acquired CapBio back in 2022.. it's been pretty hush hush – CapBio has never accepted my requests for interviews, so I'm excited to see this approval, mostly because my son really really needs it! https://www.drugdeliverybusiness.com/tandem-capbio-fda-clearance-insulin-infusion-set/ XX   Insulet just announced via an email to health care providers that Dexcom G7 compatibility with the Omnipod 5 iPhone app will be released IN THE COMING WEEKS! Great news for people with #t1d and XX Sernova announces positive interim data from its ongoing Phase 1/2 clinical trial in patients with T1D. this is their Cell Pouch Bio-hybrid Organ as a functional cure for type 1 diabetes (T1D), today Interim data from 12 patients with transplanted human donor islet cells show patients achieving insulin independence, islet cell engraftment in Cell Pouch, islet function, islet survival, improved glycemic control, improved patient reported quality of life (QOL) and improved awareness of hypoglycemia and increased sensitivity to severe hypoglycemic symptoms. Improvement in patient outcomes was correlated with a cumulative increase in the quantity of transplanted islets. Based on these findings, the study is on track to meet its primary and secondary endpoints, and the confirmatory Cohort C is expected to initiate in H2 2025.   Clinical trials with iPSC islet-like clusters from Sernova's partner, Evotec, are anticipated to begin in 2026 after completion of Cohort C of the ongoing trial. These interim findings, with 8 of 12 patients achieving insulin independence so far, support the thesis that Sernova's high volume ten channel Cell Pouch, used in Cohort B, plus an optimised immune suppression regimen, has the potential to achieve insulin independence, without portal vein transplant, in our planned clinical trial with Evotec's high quality iPSC islet-like clusters. Measured HbA1c (a blood test that shows the average blood sugar levels over the past 2-3 months) in patients with Cell Pouch alone, showed that 9 of 12 patients had a reduced value within the American Diabetes Association (ADA) recommended range of

If you're struggling with chronic fatigue syndrome (ME/CFS) or debilitating tiredness that just won't go away, you're not alone—and you're not imagining things. Millions of people suffer from persistent fatigue that conventional medicine often fails to resolve. Fatigue and stress can make everyday tasks like working at a computer feel overwhelming, as seen in this image, which represents the experience of many with chronic fatigue syndrome (ME/CFS) At the Hedberg Institute, I'm always researching botanical compounds that support microcirculation, mitochondrial health, and immune regulation—all vital in restoring energy. That's why I formulated VascuSelect, a synergistic supplement that contains three powerful plant extracts: Ginkgo biloba, grape seed extract, and mango whole fruit powder. Let's dive into why Ginkgo biloba, in particular, stands out for those dealing with ME/CFS and how it works alongside other ingredients in VascuSelect to support your energy and vitality. An Important Study: Ginkgo Biloba for ME/CFS A recent paper published in Frontiers in Pharmacology (2022) titled “A Botanical Product Containing Cistanche and Ginkgo Extracts Potentially Improves Chronic Fatigue Syndrome Symptoms in Adults: A Randomized, Double-Blind, and Placebo-Controlled Study” sheds important light on Ginkgo's role in combating chronic fatigue. In this gold-standard clinical trial, 101 adults with ME/CFS received a botanical supplement combining Ginkgo biloba extract (120 mg/day) and Cistanche tubulosa extract (300 mg/day) or a placebo for 60 days. The results were impressive: Significant reductions in fatigue severity Improved physical performance and VO₂ max Enhanced antioxidant status and reduced oxidative stress markers Improved sleep quality and concentration Enhanced quality of life (QOL) and sexual life (SLQ) scores Decreased blood levels of lactic acid and ammonia (both fatigue biomarkers) What's particularly exciting is that Ginkgo biloba played a central role in this formulation. The authors noted that Ginkgo's flavonoids and terpenoids contribute to neuroprotection, vasodilation, and mitochondrial support, all of which are key areas of dysfunction in ME/CFS patients. This study confirms that Ginkgo biloba, known for enhancing blood flow and antioxidant activity, can play a central role in reducing the burdens of ME/CFS. How Ginkgo Biloba Helps Fight Fatigue Ginkgo biloba (standardized to 24% flavonol glycosides and 6% terpenes) is one of the most studied botanical extracts for circulatory and cognitive health. But its applications go far beyond brain support—especially for those with energy-depleting illnesses like ME/CFS. Ginkgo biloba is one of the oldest and most studied medicinal plants. It's been used for centuries in Traditional Chinese Medicine, but modern science is now validating its applications for conditions like ME/CFS, fibromyalgia, and Long COVID. 1. Improves Microcirculation Ginkgo biloba increases blood flow, especially in the small vessels of the brain and extremities. This is critical in ME/CFS, where impaired oxygen delivery to tissues can worsen fatigue. 2. Supports Mitochondrial Function Many people with ME/CFS experience dysfunctional mitochondria—the energy-producing engines of cells. Ginkgo has been shown to protect mitochondrial membranes and improve ATP production, helping the body generate more usable energy. 3. Reduces Oxidative Stress Oxidative stress is a hallmark of ME/CFS and contributes to inflammation, brain fog, and fatigue. Ginkgo's rich flavonoid profile helps neutralize free radicals and reduce oxidative damage. In the study mentioned above, participants taking Ginkgo and Cistanche showed significant increases in antioxidant enzymes like SOD and CAT. 4. Enhances Neurotransmitter Function Ginkgo biloba modulates neurotransmitters like dopamine, serotonin, and norepinephrine—chemicals that regulate mood,

On a scale of 1-10 how would you rate your Quality of Life (QOL) right now?  Today Allan Crockett returns as our guest as we rip the band aid off the question that may be bouncing off the walls of your mind, "Is this the Quality of Life that I want going forward? We take a three-leg'd approach as we start with looking at how we can generate "Time and Money" in one area of a QOL, then we discuss "Relationships" as a second leg and is our dedication to the business a higher priority than our relationships, and we end on "Purpose".  If you're lying on your death bed, are you going to be happy with how you fulfilled your purpose in life? So again, I ask, how would you rate your quality of life? Do you have all the time and money you need, are your relationship healthy, and are you fulfilling your purpose in Life? If it's all good, no need to listen on, but if one or more of those three areas are lacking… then listen in! #workingranchmagazine #ranchlife #ranching #dayweather #weather #agweather #beef #cows #livestock #cattle #cowpunchercoffee #productivity #happyranching #legacy #parasite #Norbrook #Tauramox

Hazaa! Our first balance patch of Path of Exile 2's Early Access! We played as much as we could today (launch day) before recording and, no joke, could have easily doubled the length of the episode. GGG's 0.2.0 patch is out and it's loaded with changes to fuel us for months! We hope you're enjoying Dawn of the Hunt! Thanks, as always for your listens each week. You all rock!(00:00:00) Welcome and Grip It and Rip It(00:01:00) Patrons, Drinks, and After Dark Vibes(00:04:45) GGG Apology and Calendar Confession(00:08:30) Home Repairs, Squirrels, and Skate Parks(00:12:00) Path of Exile Begins – Patch 0.2.0 Hype(00:15:00) The Reveal vs The Q&A(00:18:45) UI Improvements and Subtle Changes(00:22:00) Skill Balance and Unlisted Fixes(00:25:45) Mapping, QoL, and Controller Updates(00:30:15) Resistances, Quest Zones, and Boss Icons(00:34:00) Private Leagues and Future Content(00:39:00) League Starters and Build Discussion(00:43:00) Poison and Minion Builds in 0.2(00:47:30) Progression Speed and Campaign Thoughts(00:52:00) Loot Impressions and Gear Drops(00:57:00) Enemy Density and Pack Spacing(01:01:00) Accessibility and New Player Experience(01:05:45) GGG Direction, Trust, and Player Feedback(01:10:30) Final Thoughts and Episode Wrap-UpForever Exiled Info:www.foreverexiled.comPatreonTwitter @ForeverExiled82Path of Exile WebsiteWrecker of Days Builds ListDiscord...FE Merch StoreFE Nexus Store